ImmunoCellular Therapeutics Company

ImmunoCellular Therapeutics is focused on improving cancer treatment and diagnosis through the development of new immune-based products.
Technology: Cell therapy
Industry: Public
Headquarters: Calabasas, California, United States
Founded Date: 2006-01-01
Employees Number: 1-10
Funding Status: IPO
Investors Number: 2
Total Funding: 32470645
Estimated Revenue: $10M to $50M
Last Funding Date: 2015-09-24
Last Funding Type: Grant

Visit Website
info@imuc.com
http://twitter.com/ImmunoCellular
Register and Claim Ownership